back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-21 16:42 Tx date 2024-03-20 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-150.00
-1,000 vol $0.15 each |
256,000 | |
| Filed 2024-03-21 16:41 Tx date 2024-03-21 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-900.00
-9,000 vol $0.10 each |
247,000 | |
| Filed 2024-03-07 16:06 Tx date 2024-03-07 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$630.00
+42,000 vol $0.015 each |
257,000 | |
| Filed 2023-11-01 13:55 Tx date 2023-10-31 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,800
+320,000 vol $0.015 each |
1,173,500 | |
| Filed 2023-09-28 16:26 Tx date 2023-09-28 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$90.00
+6,000 vol $0.015 each |
799,500 | |
| Filed 2023-09-28 16:22 Tx date 2023-09-27 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$915.00
+61,000 vol $0.015 each |
793,500 | |
| Filed 2023-09-27 00:49 Tx date 2023-09-26 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+25,000 vol $0.015 each |
732,500 | |
| Filed 2022-11-30 16:52 Tx date 2022-11-30 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+15,000 vol $0.02 each |
215,000 | |
| Filed 2022-11-29 17:58 Tx date 2022-11-29 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+50,000 vol $0.02 each |
200,000 | |
| Filed 2022-11-29 17:57 Tx date 2022-06-20 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2022-07-19 18:33 Tx date 2022-07-19 |
$MBI
Many Bright Ideas Technologies Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+150,000 vol $0.03 each |
707,500 | |
| Filed 2021-02-18 13:56 Tx date 2021-02-17 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,900
-54,500 vol $0.20 each |
557,500 | |
| Filed 2021-02-18 13:53 Tx date 2021-02-17 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-80,000 vol $0.20 each |
612,000 | |
| Filed 2021-02-18 13:53 Tx date 2021-02-16 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,000
-300,000 vol $0.14 each |
692,000 | |
| Filed 2021-02-10 17:22 Tx date 2021-01-07 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Weir-Jones Engineering Consultants Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+2,000,000 vol $0.05 each |
4,077,451 | |
| Filed 2021-02-10 17:16 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Weir-Jones Engineering Consultants Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,077,451 | ||
| Filed 2020-04-29 14:03 Tx date 2020-04-27 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,200,000 vol |
2,077,452 | |
| Filed 2019-09-24 16:31 Tx date 2019-09-24 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,450
+49,000 vol $0.05 each |
992,000 | |
| Filed 2019-06-21 13:43 Tx date 2019-06-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$60,000
+1,200,000 vol $0.05 each |
1,250,000 | |
| Filed 2019-06-21 13:39 Tx date 2019-06-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$60,000
+1,200,000 vol $0.05 each |
1,272,000 | |
| Filed 2019-06-04 13:12 Tx date 2019-06-03 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$640.00
+16,000 vol $0.04 each |
943,000 | |
| Filed 2019-05-09 20:15 Tx date 2019-04-26 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+10,000 vol $0.04 each |
927,000 | |
| Filed 2019-05-09 20:14 Tx date 2019-04-17 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+10,000 vol $0.04 each |
917,000 | |
| Filed 2019-05-09 20:14 Tx date 2019-04-15 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,280
+32,000 vol $0.04 each |
907,000 | |
| Filed 2019-05-09 20:13 Tx date 2019-04-15 |
$MBI
Med BioGene Inc. |
Naughty, Blair Lawrence
3 - 10% Security Holder of Issuer
Holder: Canal Front Investments Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
875,000 | ||
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,500 vol |
1,500 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-450,000 vol |
50,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,980,000 vol |
220,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-648,000 vol |
72,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,701,000 vol |
189,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,210,000 vol |
690,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,897,068 vol |
877,452 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-180,231 vol |
20,026 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Holder: Jonjit Singh (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-564,430 vol |
62,715 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,080,000 vol |
120,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-40,500 vol |
4,500 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,530,000 vol |
170,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Diebolt, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-630,000 vol |
70,000 | |
| Filed 2017-12-19 Tx date 2017-12-19 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,080,000 vol |
120,000 | |
| Filed 2017-02-21 Tx date 2017-02-17 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,700,000 | |
| Filed 2017-02-17 Tx date 2017-02-17 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
8,774,520 | |
| Filed 2017-02-03 Tx date 2016-10-24 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-297.50
-8,500 vol $0.035 each |
200,257 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,500,000 vol |
6,900,000 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,200,000 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
2,200,000 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,200,000 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Diebolt, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
700,000 | |
| Filed 2017-01-04 Tx date 2017-01-03 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
700,000 | |
| Filed 2016-11-16 Tx date 2016-11-16 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$232.80
+8,000 vol $0.0291 each |
720,000 | |
| Filed 2016-05-13 Tx date 2016-05-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+890,000 vol |
8,624,520 | |
| Filed 2016-05-13 Tx date 2016-05-12 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+890,000 vol |
1,890,000 | |
| Filed 2016-01-20 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Holder: Jonjit Singh (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$271.15
+3,190 vol $0.085 each |
627,145 | |
| Filed 2016-01-20 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Holder: Jonjit Singh (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,310
+18,728 vol $0.07 each |
623,955 | |
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,319
+30,000 vol $0.0773 each |
7,734,520 | |
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,040
+24,000 vol $0.085 each |
7,704,520 | |
| Filed 2016-01-05 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+54,000 vol $0.05 each |
||
| Filed 2016-01-04 Tx date 2015-12-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+54,000 vol $0.05 each |
7,734,520 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
700,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
450,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Diebolt, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
450,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
700,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
2,400,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
450,000 | |
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
||
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2015-02-11 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$132,626
+2,652,520 vol $0.05 each |
7,680,520 | |
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+1,000,000 vol $0.05 each |
||
| Filed 2015-10-02 Tx date 2014-09-29 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+1,000,000 vol $0.05 each |
||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-02 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Elizabeth Weir-Jones (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-23 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-09-23 Tx date 2015-03-02 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-23 Tx date 2015-03-02 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
208,757 | ||
| Filed 2015-09-23 Tx date 2015-03-02 |
$MBI
Med BioGene Inc. |
Sidhu, Shumsheer
4 - Director of Issuer
Holder: Jonjit Singh (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
605,227 | ||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Iain
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Ghobrial, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Friedlander, Terence
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-22 Tx date 2015-05-20 |
$MBI
Med BioGene Inc. |
Diebolt, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-09-22 Tx date 2014-09-05 |
$MBI
Med BioGene Inc. |
Diebolt, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-31 Tx date 2015-07-31 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41.40
+1,000 vol $0.0414 each |
712,000 | |
| Filed 2015-06-05 Tx date 2015-06-05 |
$MBI
Med BioGene Inc. |
Weir-Jones, Toby
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58.80
+1,000 vol $0.0588 each |
711,000 |